USPTO serial 79165656
Reviewed by CopyMark Law Group
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $3,400
F-59000 LILLE, FR
LILLE, FR
F-59000 LILLE, FR
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
James J. Bitetto
James J. Bitetto Tutunjian & Bitetto, P.C.401 Broadhollow RoadSuite 402Melville, NY 11747| Class | Description | Status | First use |
|---|---|---|---|
| 001 | [ Chemicals, other than for use in immunodiagnostics and HIV tests, for use in industry, science, as well as in agriculture, horticulture and forestry except fungicides, herbicides, insecticides and parasiticides; ] chemical preparations for making diagnoses in laboratories other than for medical or veterinary purposes and other than immunodiagnostics and HIV tests; [ chemical reagents, other than those used for medical, veterinary, immunodiagnostic and HIV tests; biological, biochemical, and chemical reagents for non-medical purposes for the improvement of molecules, other than those used for HIV and immunodiagnostics tests; ] biological preparations other than for medical or veterinary use for use for identifying and testing various complex microbiological samples, including human micro biota, soils, water, air and food; chemical products for creating genetic marker libraries in order to genotype a complex micro biota population and for making diagnoses in laboratories other than for medical or veterinary purposes for use in the fields of biology, biotechnology, biochemistry, genomics, proteomics, transcriptomics, genetics and life sciences, other than those used for HIV and immunodiagnostics tests; diagnostic kits comprised of bio chemicals, namely, cells, antibodies, antigens, and gene banks containing bio technologically formed genes, as well as mutation and molecular variant banks containing bio technologically formed genes for in vitro scientific research use and for diagnostics not for medical or veterinary purposes | ACTIVE | — |
| 005 | [ Pharmaceutical products, namely, pharmaceutical products for treatment of cancer, infectious diseases, tuberculosis and for Alzheimer detection and treatment; veterinary products, namely, veterinary products for treatment of cancer, infectious diseases, tuberculosis and Alzheimer detection and treatment; chemical preparations for medical use in the treatment of cancer, infectious diseases, tuberculosis and Alzheimer detection and treatment; ] diagnostic preparations for medical and veterinary use but not for immunodiagnostic and HIV tests; diagnostic products for medical use, namely, reagents and assays [; chemical reagents for medical or veterinary purposes but not for immunodiagnostic and HIV tests; preparations of microorganisms for medical and veterinary use ] | ACTIVE | — |
| 009 | [ Measuring instruments and devices, namely, research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; computer programs for research and analysis in the fields of science, biology, biotechnology, biochemistry, genomics, proteomics, transcriptomics, genetics, life sciences, cloning, human health, diagnostics and in the processing of biological data; software for scientific analysis of genetic sequences and biological platelets for use in the scientific research industry and in the field of genetics; ] computer programs and software incorporating algorithms designed for research and analysis in the fields of science, biology, biotechnology, biochemistry, genomics, proteomics, transcriptomics, genetics, life sciences, cloning, human health, diagnostics and in the processing of biological data [; computer programs designed for scientific analysis of genetic sequences and biological platelets for use in scientific research; computer programs designed to identify DNA, detect diseases, test and develop drugs; analysis apparatus, not for medical use, namely, scales, sequencers, analyzers and captors; apparatus for testing air, water, food, namely, scales, sequencers, analyzers and captors; chemistry apparatus and instruments, namely, sequencers, chemistry analyzers and captors ;diagnostic apparatus, not for medical use, namely, sequencers, analyzers and captors; electronic quantity indicators for measuring blood and other bodily fluids; measuring instruments, namely, scales, analyzers and captors; DNA chips ] | ACTIVE | — |
| 042 | Evaluations, analyses, scientific research and technological testing services of flora, metagenomes, microorganisms, micro biota or transcriptomics in the field of [ pharmacy, chemistry, ] biotechnology, [ biochemistry, ] genomics, bacteriology, transcriptomics, genetics, and life sciences; [ biomedical research, and biological, medical and veterinary product development; providing laboratory research services in the field of gene expression and protein profiling, namely, cancer infectious diseases, tuberculosis, Alzheimer biology; ] genotyping services for research and analysis purposes for genotyping based on biological markers; design and development of programming databases in the field of [ pharmaceuticals, ] biotechnology, biology, [ biochemistry, ] genomics, transcriptomics, genetics, and life sciences; clinical laboratory testing services, namely, gene sequencing-based testing services with a view to research relating to genome sequencing of plants and animals, micro-organisms, sequencing of DNA or RNA and epigenetic sequencing; development and updating of computer programs designed for scientific analysis of genetic sequences, genetic sequencing of the genes of individuals and cohorts; [ electronic data storage and computer programming services for publishing data in a computer science environment designed for bioinformatics; bioinformatics computer engineering; laboratory research services in the field of large-scale DNA sequencing; development and updating of data management systems; database design and development applications in general of biological data processing; scientific development and technical validation of micro-satellite and mini-satellite markers; scientific services in the field of genomics for use in laboratories working on all kinds genomes, including human, animal and micro-organisms, namely, scientific development and validation of micro-satellite and mini-satellite markers; ] scientific services in the field of genomics for use in laboratories working on all kinds genomes, including human, animal and micro-organisms, namely, identification, typing, tracing, analysis and creation of a bank and a database, treatments resistance prediction, whole genome sequencing and complete flora; scientific research, mutation detection and identification of microorganisms; [ scientific research, namely, mutation detection and identification of microorganisms; genotyping services for research or analyses purposes; ] development and testing of computer databases, software, algorithms and computing methods for generating and analyzing biological, genetic and epidemiological data [; scientific research and development services in the fields of diagnostic methods, antibody technology, and gene expression systems; rental of software and computer databases; scientific research and development services; medical laboratory services ] | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 11, 2026 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Sep 11, 2026 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Aug 24, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| May 21, 2026 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Jun 21, 2025 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Feb 13, 2025 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Jun 8, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 8, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 8, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 13, 2022 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Dec 13, 2022 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Dec 9, 2022 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Nov 30, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 30, 2022 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Nov 30, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 30, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 30, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 30, 2022 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Nov 30, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 30, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 9, 2022 | PUM1 | OFFICE ACTION ISSUED POU1 | — |
| Jun 8, 2022 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jun 2, 2022 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Jun 21, 2021 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jul 9, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 16, 2016 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 22, 2016 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 22, 2016 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 21, 2016 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 12, 2016 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 21, 2016 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 5, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 5, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 1, 2016 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 16, 2016 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 16, 2016 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 16, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 2, 2016 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 22, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 30, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 30, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 30, 2015 | ALIE | ASSIGNED TO LIE | — |
| Dec 10, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 27, 2015 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 10, 2015 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 10, 2015 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 8, 2015 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 7, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 5, 2015 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 1, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 1, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 30, 2015 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |